Amorfix Life Sciences is a theranostics company dedicated to becoming the world leader in the diagnosis and treatment of Aggregated Misfolded Protein (AMP) diseases of the brain.

The Aggregated Misfolded Protein diseases include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).

June 24, 2008:
Press Release Amorfix Achieves Target Sensitivity with its Alzheimer’s Disease
Diagnostic Test

View the presentation by Dr. George Adams, CEO
at the Rodman & Renshaw 5th Annual Global Healtcare Conference
Click here to launch the webcast

© Amorfix Life Sciences Ltd.